跳至主要内容
临床试验/NCT05408208
NCT05408208Unknown不适用

Efficacy Of Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis

Sohag University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年5月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Efficacy Of Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis

研究概览

简要总结

The aim of the present study is to evaluate the efficacy of intralesional injection of methotrexate in comparison with Intralesional Injection of Triamcinolone Acetonid in localized psoriasis (body surface area < 10%) .

详细描述

study enrolling 30 patients of localized psoriasis. 15 patients received intralesional methotrexate :

  • Taking aseptic condition ,One psoriatic plaque will treated with Intralesional injection of methotrexate (25mg /ml) at dosage of 0.1 ml /cm2.
  • Another plaque will treated with intralesional ingection of distilled water as controlled plaque.
  • patient will receive oral folic acid 5mg tablet every day except the day of injection.

Other 15 patients received intralesional trimethinolone acetonide:

  • Taking aseptic condition , One plaque will treated with Intralesional injection of trimethinolone acetonide (10mg/ml) at dosage of 0.1 ml/ cm2 .
  • another plaque will treated with Intralesional injection of distilled water as controed plaque.
  • Patients will take 6 sessions every 2 weeks for 3 months and will followed up at 2 month and 3 months after treatment .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with localized Psoriasis (body surface area<10%)

排除标准

  • Patient refusal. Generalized psoriasis. Pregnancy. Lactation. Immunocompromised patients . Patients with history of hypersensitivity to methotrexate. Patients with other inflammatory skin disorders. Patients with chronic hepatic, renal , pulmonary ,or haematological disorders. patients on treatment for psoriasis .

研究组 & 干预措施

Methotrexate

Active Comparator

Intralesional injection of methotrexate

干预措施: Intralesional Injection of Methotrexate (Drug)

Methotrexate

Active Comparator

Intralesional injection of methotrexate

干预措施: Triamcinolone Acetonid (Drug)

Triamcinolone Acetonid

Active Comparator

Intralesional injection of trimethinolone acetonide

干预措施: Intralesional Injection of Methotrexate (Drug)

Triamcinolone Acetonid

Active Comparator

Intralesional injection of trimethinolone acetonide

干预措施: Triamcinolone Acetonid (Drug)

结局指标

主要结局

Efficacy Of Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis

时间窗: 3 months after treatment

clinical and dermoscopic changes according to psoriasis area severity index

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gehad Hamdy Abdelgaber

Gehad Hamdy

Sohag University

研究点 (1)

Loading locations...

相似试验